Orchid Pharma Limited has informed the Exchange about Schedule of meet
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma has informed the exchanges that its Whole Time Director, Mr. Mridul Dhanuka, will attend an investor meet on Wednesday, August 19, 2025, at 2:00 PM in Mumbai. The meeting will be held in physical mode. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during this meet. This is a routine disclosure under SEBI's listing regulations to keep the market informed of management's engagement with investors.
This is a routine investor engagement disclosure with no material business update. Shareholders should not expect any new strategic announcement from this meet, as the company has explicitly stated no UPSI will be shared. Stock price is unlikely to be materially impacted.